The combination of a serotonin reuptake inhibitor and a...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/566 (2006.01)

Patent

CA 2643922

The invention relates to the use of a compound, which is a serotonin reuptake inhibitor, and another compound, which is H3 receptor antagonist, inverse agonist or partial agonist for the preparation of a pharmaceutical composition for the treatment of depression, anxiety disorders and other affective disorders, such as generalized anxiety disorder, panic anxiety, obsessive compulsive disorder, acute stress disorder, post traumatic stress disorder and social anxiety disorder, eating disorders such as bulimia, anorexia and obesity, phobias, dysthymia, premenstrual syndrome, cognitive disorders, impulse control disorders, attention deficit hyperactivity disorder, drug abuse or any other disorder responsive to serotonin reuptake inhibitor.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

The combination of a serotonin reuptake inhibitor and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The combination of a serotonin reuptake inhibitor and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The combination of a serotonin reuptake inhibitor and a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1500768

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.